Literature DB >> 2678224

Properties and applications of photodynamic therapy.

C J Gomer1, N Rucker, A Ferrario, S Wong.   

Abstract

Photodynamic therapy (PDT) is the treatment of malignant lesions with visible light following the systemic administration of a tumor-localizing photosensitizer. Pharmacological and photochemical properties of the photosensitizer are combined with precise delivery of laser-generated light to produce a treatment which can offer selective tumoricidal action. Hematoporphyrin derivative (HD) and a purified component called Photofrin II are currently being used in clinical PDT. Initial patient results have been encouraging, and considerable interest has developed in the synthesis and evaluation of new photosensitizers with improved photochemical and pharmacological characteristics. In addition, there has been a gradual increase in knowledge related to in vitro and in vivo mechanisms of action of PDT. This report provides an overview of the properties and applications of PDT. Information and data related to drug development, photochemistry, subcellular targets, in vivo responses, and clinical trials of PDT are presented.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2678224

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  23 in total

1.  Dosedependent photodynamic effects of 9-acetoxy-2,7,12,17-tetrakis(\-methoxyethyl)-porphycene in vitro.

Authors:  S Karrer; R M Szeimies; A Ebert; S Fickweiler; C Abels; W Bäumler; M Landthaler
Journal:  Lasers Med Sci       Date:  1997-12       Impact factor: 3.161

2.  Apoptotic effect of pheophorbide a-mediated photodynamic therapy on DMBA/TPA-induced mouse papillomas.

Authors:  Xianglan Zhang; Eun Joo Choi; Zhenlong Zheng; Lianhua Zhu; Sung Bin Cho; Ki-Yoel Kim; Jin Kim; In-Ho Cha
Journal:  Lasers Med Sci       Date:  2014-06-21       Impact factor: 3.161

3.  Apoptotic signalling cascade in photosensitized human epidermal carcinoma A431 cells: involvement of singlet oxygen, c-Jun N-terminal kinase, caspase-3 and p21-activated kinase 2.

Authors:  W H Chan; J S Yu; S D Yang
Journal:  Biochem J       Date:  2000-10-01       Impact factor: 3.857

4.  Diagnosis, Staging, and Treatment of Cholangiocarcinoma.

Authors:  Jung-Hwan Yoon; Gregory J. Gores
Journal:  Curr Treat Options Gastroenterol       Date:  2003-04

5.  Therapeutic effects of systemic photodynamic therapy in a leukemia animal model using A20 cells.

Authors:  Lan Ying Wen; Su-Mi Bae; Heung-Jae Chun; Kye-Shin Park; Woong Shick Ahn
Journal:  Lasers Med Sci       Date:  2011-07-18       Impact factor: 3.161

6.  Potentiation of hyperthermia-induced haemolysis of human erythrocytes by photodynamic treatment. Evidence for the involvement of the anion transporter in this synergistic interaction.

Authors:  C Prinsze; K Tijssen; T M Dubbelman; J Van Steveninck
Journal:  Biochem J       Date:  1991-07-01       Impact factor: 3.857

7.  Tetrakis(p-carboranylthio-tetrafluorophenyl)chlorin (TPFC): application for photodynamic therapy and boron neutron capture therapy.

Authors:  Ryo Hiramatsu; Shinji Kawabata; Hiroki Tanaka; Yoshinori Sakurai; Minoru Suzuki; Koji Ono; Shin-ichi Miyatake; Toshihiko Kuroiwa; Erhong Hao; M Graça H Vicente
Journal:  J Pharm Sci       Date:  2014-12-26       Impact factor: 3.534

8.  5-ALA mediated photodynamic therapy induces autophagic cell death via AMP-activated protein kinase.

Authors:  Hong-Tai Ji; Li-Ting Chien; Yu-Hsin Lin; Hsiung-Fei Chien; Chin-Tin Chen
Journal:  Mol Cancer       Date:  2010-04-28       Impact factor: 27.401

9.  Factors affecting recognition of cancer risks of nuclear workers.

Authors:  G W Kneale; A M Stewart
Journal:  Occup Environ Med       Date:  1995-08       Impact factor: 4.402

10.  Selective phototoxic destruction of rat Merkel cells abolishes responses of slowly adapting type I mechanoreceptor units.

Authors:  I Ikeda; Y Yamashita; T Ono; H Ogawa
Journal:  J Physiol       Date:  1994-09-01       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.